As well, the levels of FSH (52.415 and 51.39 pg/ml, respectively) in patients with strong tumor ER or PR expression were lower than those in patients without tumor ER or PR expression (55.6 and 53.9 pg/ml, P = 0.03 and P = 0.031, respectively). Here, BRD2 is linked to neoplasm.